Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness Study of the AngioSafe Peripheral CTO Crossing System

NCT04663867 is registered in ClinicalTrials.gov with AngioSafe, Inc. as lead sponsor.

NCT NCT04663867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04663867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness Study of the AngioSafe Peripheral CTO Crossing System
Lead sponsor
AngioSafe, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 3, 2021
Completion date
June 15, 2023
Enrollment
79 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease, peripheral artery occlusion